January 10, 2022

WuXi Global Forum 2022

Date and time

January 10, 2023 ~ January 10, 2023

8am - 11am PST | 7pm - 10pm PST

11am - 2pm EST | 10pm - 1am EST

REGISTER NOWREGISTERED

Dear Colleagues & Friends,

We are honored to have been able to unite thousands of colleagues this year from around the world for the 10th annual WuXi Global Forum 2022 on January 10th, 2022. Together we were able to tackle some of the biggest challenges facing our industry and catalyze actionable solutions for patients.

With the theme of “Advancing Breakthroughs for Patients,” this year’s Forum included twenty-three industry leaders on a total of 6 panels. They addressed key topics and questions relevant to the current and future state of the healthcare and biotechnology industry.

To our esteemed guest speakers, THANK YOU for leading the way with new thinking and actionable approaches as we work together to shape the future of healthcare.

Special thanks to our supportive partners: BioCentury, Biocom California, Clarivate, California Life Sciences, Endpoints News, Fierce Biotech, GEN, MBC BioLabs, Medicon Valley Alliance, QB3, Swiss Biotech Association and UK BioIndustry Association.

Thank you again, and make sure to follow us on Twitter and LinkedIn to stay up-to-date on upcoming WuXi AppTec news and events.

Agenda

08:00 AM - 08:05 AM Welcome
Hui Cai, Program Chair, VP and Head of Content, WuXi AppTec
08:05 AM - 08:10 AM Opening Remarks
Minzhang Chen, Co-CEO, WuXi AppTec
08:10 AM - 08:45 AM Opening Plenary: Changing the Games of R&D Productivity
David Berry, Founder and CEO, Valo Health
Diego Miralles, CEO, Laronde
Roger Perlmutter, Chairman & CEO, Eikon Therapeutics
Henrijette Richter, Managing Partner, Sofinnova Partners
Session Leader: Jorge Conde, General Partner, Andreessen Horowitz
08:45 AM - 09:10 AM A Special Tribute to Dr. José Baselga
A Conversation between Susan Galbraith, EVP, Oncology R&D, AstraZeneca and David Reese, EVP of R&D, Amgen
09:10 AM - 09:30 AM A Special Tribute to Dr. Tachi Yamada
A Conversation with James Wilson, Professor of Medicine and Pediatrics of Department of Medicine, and Director of Gene Therapy Program, University of Pennsylvania. Moderated by John Carroll, Chief Editor & Founder, Endpoints News
09:30 AM - 10:10 AM Investing for Social Impact
Christiana Bardon, Co-Managing Partner of BioImpact Capital, MPM Capital
Jürgen Eckhardt, SVP and Head of Leaps by Bayer
Alice Pomponio, Managing Director, American Cancer Society BrightEdge
Glenn Rockman, Founder and Managing Partner, Adjuvant Capital
Session Leader: Laura Kleiman, Founder and CEO, Reboot Rx
10:10 AM - 10:50 AM Delivering on the Promise of New Modalities
Debora Barton, CMO, Carisma Therapeutics
John Houston, President and CEO, Arvinas
Eric Kelsic, Founder & CEO, Dyno Therapeutics
Devyn Smith, CEO, Arbor Biotechnologies
Session Leader: Ryan Cawood, CSO, WuXi Advanced Therapies and OXGENE
10:50 AM - 11:10 AM Closing Keynote
A Conversation with Todd Golub, Director, Broad Institute of MIT & Harvard. Moderated by Kevin Davies, Executive Editor, The CRISPR Journal and GEN Biotechnology; and Author, Editing Humanity

Speakers

Hui Cai
PROGRAM CHAIR, VP AND HEAD OF CONTENT, WUXI APPTEC
Minzhang Chen
CO-CEO, WUXI APPTEC
David Berry
FOUNDER AND CEO, VALO HEALTH
Diego Miralles
CEO, LARONDE
Roger Perlmutter
CHAIRMAN & CEO, EIKON THERAPEUTICS
Henrijette Richter
MANAGING PARTNER, SOFINNOVA PARTNERS
Jorge Conde
GENERAL PARTNER, ANDREESSEN HOROWITZ
Susan Galbraith
EVP, ONCOLOGY R&D, ASTRAZENECA
David Reese
EVP OF R&D, AMGEN
James Wilson
PROFESSOR OF MEDICINE AND PEDIATRICS OF DEPARTMENT OF MEDICINE, AND DIRECTOR OF GENE THERAPY PROGRAM, UNIVERSITY OF PENNSYLVANIA
John Carroll
CHIEF EDITOR & FOUNDER, ENDPOINTS NEWS
Christiana Bardon
CO-MANAGING PARTNER OF BIOIMPACT CAPITAL, MPM CAPITAL
Jürgen Eckhardt
SVP AND HEAD OF LEAPS BY BAYER
Alice Pomponio
MANAGING DIRECTOR, AMERICAN CANCER SOCIETY BRIGHTEDGE
Glenn Rockman
FOUNDER AND MANAGING PARTNER, ADJUVANT CAPITAL
Laura Kleiman
FOUNDER AND CEO, REBOOT RX
Debora Barton
CMO, CARISMA THERAPEUTICS
John Houston
PRESIDENT AND CEO, ARVINAS
Eric Kelsic
FOUNDER & CEO, DYNO THERAPEUTICS
Devyn Smith
CEO, ARBOR BIOTECHNOLOGIES
Ryan Cawood
CSO, WUXI ADVANCED THERAPIES AND OXGENE
Todd Golub
DIRECTOR, BROAD INSTITUTE OF MIT & HARVARD
Kevin Davies
EXECUTIVE EDITOR, THE CRISPR JOURNAL AND GEN BIOTECHNOLOGY; AUTHOR, EDITING HUMANITY